Literature DB >> 21321998

Effect of β-amyloid (25-35) on mitochondrial function and expression of mitochondrial permeability transition pore proteins in rat hippocampal neurons.

Rui Ren1, Yang Zhang, Benchang Li, Yanping Wu, Baixiang Li.   

Abstract

The aim of this study was to assess the effect of the β-amyloid fragment Aβ(25-35) on mitochondrial structure and function and on the expression of proteins associated with the mitochondrial permeability transition pore (MPTP) in rat hippocampal neurons. Ninety clean-grade Sprague-Dawley rats were randomly assigned to six groups (n = 15 per group). Aβ(25-35) (1, 5, or 10 µg/rat) was injected into hippocampal area CA1. Normal saline was injected as a control. The effect of Aβ(25-35) injection on hippocampal structure was assessed by transmission electron microscopy. Ca(2+) -ATPase activity, [Ca(2+) ](i) , and mitochondrial membrane potential were measured. The expression of genes associated with the MPTP, including the voltage-dependent anion channel (VDAC), adenine nucleotide translocator (ANT), and cyclophilin D (Cyp-D), were evaluated. Results showed that Aβ(25-35) injection damaged the mitochondrial structure of hippocampal neurons, decreased Ca(2+) -ATPase activity and mitochondrial membrane potential, and increased [Ca(2+) ](i) . The expression levels for VDAC, ANT, and Cyp-D in all groups were significantly (P < 0.05) higher than those in the normal control group after Aβ(25-35) injection. These results indicate that Aβ(25-35) damages mitochondria in rat hippocampal neurons and effects mitochondrial dysfunction, as well as increasing the expression of genes associated with the MPTP. Mitochondrial dysfunction may result in increased MPTP gene expression, leading to neurodegenerative effects.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21321998     DOI: 10.1002/jcb.23062

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  14 in total

1.  Beneficial Effect of Astragaloside on Alzheimer's Disease Condition Using Cultured Primary Cortical Cells Under β-amyloid Exposure.

Authors:  Ching-Ping Chang; Yu-Fan Liu; Hung-Jung Lin; Chien-Chin Hsu; Bor-Chih Cheng; Wen-Pin Liu; Mao-Tsun Lin; Shu-Fen Hsu; Li-Sheng Chang; Kao-Chang Lin
Journal:  Mol Neurobiol       Date:  2015-12-22       Impact factor: 5.590

Review 2.  Is the mitochondrial outermembrane protein VDAC1 therapeutic target for Alzheimer's disease?

Authors:  P Hemachandra Reddy
Journal:  Biochim Biophys Acta       Date:  2012-09-17

3.  Protective effects of hesperidin against amyloid-β (Aβ) induced neurotoxicity through the voltage dependent anion channel 1 (VDAC1)-mediated mitochondrial apoptotic pathway in PC12 cells.

Authors:  Dong-Mei Wang; San-Qiang Li; Xiao-Ying Zhu; Yong Wang; Wen-Lan Wu; Xiao-Juan Zhang
Journal:  Neurochem Res       Date:  2013-03-09       Impact factor: 3.996

Review 4.  One protein, multiple pathologies: multifaceted involvement of amyloid β in neurodegenerative disorders of the brain and retina.

Authors:  Vivek Gupta; Veer B Gupta; Nitin Chitranshi; Sumudu Gangoda; Roshana Vander Wall; Mojdeh Abbasi; Mojtaba Golzan; Yogita Dheer; Tejal Shah; Alberto Avolio; Roger Chung; Ralph Martins; Stuart Graham
Journal:  Cell Mol Life Sci       Date:  2016-06-22       Impact factor: 9.261

5.  Protective effects of astragaloside IV against amyloid beta1-42 neurotoxicity by inhibiting the mitochondrial permeability transition pore opening.

Authors:  Qinru Sun; Ning Jia; Weixi Wang; Hui Jin; Jiehua Xu; Haitao Hu
Journal:  PLoS One       Date:  2014-06-06       Impact factor: 3.240

6.  Postconditioning ameliorates mitochondrial DNA damage and deletion after renal ischemic injury.

Authors:  Xiaohua Tan; Lei Zhang; Yunpeng Jiang; Yujia Yang; Wenqi Zhang; Yulin Li; Xiuying Zhang
Journal:  Nephrol Dial Transplant       Date:  2013-09-10       Impact factor: 5.992

7.  Mitochondrial protection by the mixed muscarinic/σ1 ligand ANAVEX2-73, a tetrahydrofuran derivative, in Aβ25-35 peptide-injected mice, a nontransgenic Alzheimer's disease model.

Authors:  Valentine Lahmy; Romain Long; Didier Morin; Vanessa Villard; Tangui Maurice
Journal:  Front Cell Neurosci       Date:  2015-01-20       Impact factor: 5.505

Review 8.  Elevating the Levels of Calcium Ions Exacerbate Alzheimer's Disease via Inducing the Production and Aggregation of β-Amyloid Protein and Phosphorylated Tau.

Authors:  Pei-Pei Guan; Long-Long Cao; Pu Wang
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

Review 9.  Early onset Alzheimer's disease and oxidative stress.

Authors:  Marco Antonio Meraz-Ríos; Diana Franco-Bocanegra; Danira Toral Rios; Victoria Campos-Peña
Journal:  Oxid Med Cell Longev       Date:  2014-01-14       Impact factor: 6.543

10.  Global analysis of ginsenoside Rg1 protective effects in β-amyloid-treated neuronal cells.

Authors:  Ji Seon Shim; Min-Young Song; Sung-Vin Yim; Seung-Eun Lee; Kang-Sik Park
Journal:  J Ginseng Res       Date:  2016-12-08       Impact factor: 6.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.